GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
China Biologic Products Inc (CBPO) [hlAlert]

Rating:
Buy CBPO
up 18.19 %

China Biologic Products Inc (CBPO) rated Buy with price target $28 by Aegis Capital

Posted on: Thursday,  Mar 14, 2013  10:25 AM ET by Aegis Capital

Aegis Capital rated Buy China Biologic Products Inc (NASDAQ: CBPO) on 03/14/2013, when the stock price was $25.11. Since then, China Biologic
Products Inc has gained 18.20% of its value until Aegis Capital rated CBPO Hold on 11/06/2013, when the price was $29.68.
If you would have followed this Aegis Capital's recommendation on CBPO, you would have gained 18.19% of your investment in 237 days.

China Biologic Products, Inc. is a biopharmaceutical company and through its Chinese subsidiaries, Shandong Taibang and Qianfeng, and Huitian, the Company is engaged in the research, development and manufacturing of plasma-based pharmaceutical products in China. It sells human albumin, which represented approximately 49.7% during the year ended December 31, 2009. Human albumin is principally used to increase blood volume while immunoglobulin is used for certain disease preventions and cures. The Company sells human albumin 20%/10ml, 20%/25ml, 20%/50ml, 10%/10ml, 10%/25ml, 10%/50ml and 25%/50ml. It sells the products to customers in the People Republic of China (PRC), mainly hospitals and inoculation centers. In June 2009, it purchased 35% interest in Xi'an Huitian Blood Products Co., Ltd. On December 21, 2009, the Company established Logic Management and Consulting (China) Co., Ltd.

Aegis Capital
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/8/2014 12:00 AM Buy
None
49.58 55.00
as of 12/13/2013
1 Week   
1 Month   
3 Months up  22.34 %
1 YTD up  18.19 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/6/2013 3:25 PM Hold
None
29.68
3/14/2013 10:25 AM Buy
None
25.11 28.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy